Get started
Award

P50CA089393

Funded outputs count: 240
Funder award ID: P50CA089393
OpenAlex ID: G4258809411
Targeting c-MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications
2025 · Michelle Ji, Shridar Ganesan, et al. · Cancers · 20
PDF
Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts
2023 · Kala Visvanathan, Alison M. Mondul, et al. · European Journal of Epidemiology · 29
PDF
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
2022 · Karen S. Anderson, Timothy K. Erick, et al. · Breast Cancer Research and Treatment · 25
PDF
Temporal and spatial topography of cell proliferation in cancer
2022 · Giorgio Gaglia, Sheheryar Kabraji, et al. · Nature Cell Biology · 62
PDF
Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score
2021 · C. Benedikt Westphalen, Alexander D. Fine, et al. · Clinical Cancer Research · 77
Blood Vessel Morphologic Changes Depicted with MR Angiography during Treatment of Brain Metastases: A Feasibility Study
2020 · Carey, Lisa A., Smith, J. Keith, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
2020 · Ethan S. Sokol, Dean Pavlick, et al. · JCO Precision Oncology · 176
Evaluating the Relative Volume Change (RVC) Formula for Screening and Early Treatment of Breast Cancer-Related Lymphedema (BCRL)
2019 · Fangdi Sun · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
PDF
CRB3 and the FERM protein EPB41L4B regulate proliferation of mammary epithelial cells through the release of amphiregulin
2018 · Stephanie J. Walker, Laura M. Selfors, et al. · PLoS ONE · 3
PDF
Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?
2018 · Susan G.R. McDuff, Amir I. Mina, et al. · International Journal of Radiation Oncology*Biology*Physics · 191
Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
2018 · Sheheryar Kabraji, Jing Ni, et al. · Clinical Cancer Research · 90
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer
2017 · Hui Liu, Charles J. Murphy, et al. · Cancer Discovery · 75
Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery
2017 · Rinaa S. Punglia, Wei Jiang, et al. · Breast Cancer Research and Treatment · 19
Association Between Precautionary Behaviors and Breast Cancer–Related Lymphedema in Patients Undergoing Bilateral Surgery
2017 · Maria S. Asdourian, Meyha N. Swaroop, et al. · Journal of Clinical Oncology · 77
In response to: Letter to the Editor by Kilbreath et al.
2016 · Meyha N. Swaroop, Cheryl L. Brunelle, et al. · Journal of Surgical Oncology · 1
Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis
2016 · Maria S Asdourian, Melissa N Skolny, et al. · The Lancet Oncology · 118
The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema
2016 · Fangdi Sun, Melissa N. Skolny, et al. · Breast Cancer Research and Treatment · 77
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
2016 · Melinda L. Telli, Kirsten M. Timms, et al. · Clinical Cancer Research · 1,127
Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers
2016 · Ines Vaz-Luis, Melissa E. Hughes, et al. · Breast Cancer Research and Treatment · 20
Targeting CDK4 and CDK6: From Discovery to Therapy
2015 · Charles J. Sherr, David Beach, et al. · Cancer Discovery · 929
Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer
2015 · Chantal M. Ferguson, Meyha N. Swaroop, et al. · Journal of Clinical Oncology · 200
Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA
2015 · Bose S. Kochupurakkal, J. Dirk Iglehart · Genomics Data · 2
PDF
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
2015 · Sara M. Tolaney, Yves Boucher, et al. · Proceedings of the National Academy of Sciences · 257
PDF
RelA-Induced Interferon Response Negatively Regulates Proliferation
2015 · Bose S. Kochupurakkal, Zhigang C. Wang, et al. · PLoS ONE · 27
PDF
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)
2015 · Nancy U. Lin, Hao Guo, et al. · Journal of Clinical Oncology · 64
PDF
Year
Topic